newsfilter
← Latest News
Business Wire·

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

"Seed-and-Boost" Approach with Breakthrough Potential, Poised to Transform the Cancer Immunotherapy Landscape ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing